SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-K/A
AMENDMENT #1
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1994
Commission File Number 1-6926
C. R. BARD, INC.
(Exact name of registrant as specified in its charter)
New Jersey 22-1454160
(State of incorporation) (I.R.S. Employer Identification No.)
730 Central Avenue, Murray Hill, New Jersey 07974
(Address of principal executive offices)
Registrant's telephone number, including area code: (908) 277-8000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which registered
Common Stock - $.25 par value New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes X No
Indicate by check mark if disclosure of delinquent filers pursuant
to Item 405 of Regulation S-K is not contained herein, and will not
be contained, to the best of registrant's knowledge, in definitive
proxy or information statements incorporated by reference in Part
III of this Form 10-K or any amendments to this Form 10-K. [ X ]
The aggregate market value of the voting stock held by
nonaffiliates of the registrant was approximately $1,394,100,000
based on the closing price of stock traded on the New York Stock
Exchange on February 28, 1995. As of February 28, 1995, there were
52,115,526 shares of Common Stock, $.25 par value per share,
outstanding.
The Company's definitive Proxy Statement dated March 10, 1995 has
been incorporated by reference with respect to certain information
contained therein in Part III and Part IV of this Form 10-K.
The exhibit index is located in Part IV, Item 14, Page IV-1.
<PAGE>
C. R. Bard, Inc. filed on March 17, 1995 its annual report on Form 10-K.
Due to a "submission" tag automatically being inserted by the EDGAR system
when merging the following exhibits, the EDGAR system did not accept these
exhibits with the initial filing. C. R. Bard, Inc. is hereby amending its
initial 10-K by refiling the following three exhibits:
Exhibit 21 Parents and subsidiaries of registrant.
Exhibit 23 Arthur Andersen LLP consent to incorporation by
reference of their report on Form 10-K as amended into
previously filed Forms S-8.
Exhibit 27 Financial data schedule.
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
C. R. BARD, INC.
(Registrant)
By: William C. Bopp /s/
William C. Bopp
Senior Vice President and
Chief Financial Officer
Date: March 22, 1995
C. R. BARD, INC. AND SUBSIDIARIES
EXHIBIT 21
Parents and Subsidiaries of Registrant
The following table lists, as of December 31, 1994, the Company of
its significant subsidiaries and indicates the jurisdiction of
organization of each subsidiary and the percentage of voting
securities owned by the immediate parent of each subsidiary.
Where % of
Incorporated Voting Stock
C. R. Bard, Inc. New Jersey (Registrant)
Bainbridge Science, Inc. Washington 100
Bard Access Systems, Inc. Utah 100
Bard Canada Inc. Canada 100
Purchaseco Inc. Canada 100
Vas-Cath Holdings Ltd. Canada 100
Vas-Cath, Inc. Canada 100
Med-Pro Design Inc. Canada 100
Bard Cardiopulmonary, Inc. Delaware 100
Bard Devices, Inc. Delaware 100
Davol Inc. Delaware 100
Bard Implants, Inc. Delaware 100
Bard International, Inc. Delaware 100
Bard Japan Limited Japan 100
Bard Shannon Limited Ireland 100
Bard de Espana, S.A. Spain 100
C. R. Bard GmbH Germany 100
Angiomed AG Germany 100
Bard Portugal Portugal 100
Bard Belgium N.V. Belgium 100
Bard Galway Limited Ireland 100
Bard Holdings Limited England 100
Bard Limited England 100
Bard Nederland B.V. Netherlands 100
Bard S.P.A. Italy 100
C. R. Bard Ireland Limited Ireland 100
Laboratoires Bard S.A. France 100
Cardial S.A. France 100
BCP Puerto Rico, Inc. Delaware 100
Catalina Acquisition Corp. Delaware 100
CRB Delaware, Inc. Delaware 100
Pilot Cardiovascular Systems, Inc. Delaware 100
Roberts Laboratories, Inc. Arizona 100
The Consolidated Financial Statements include the accounts of the
Registrant and all its wholly-owned subsidiaries.
IV-69
C. R. BARD, INC. AND SUBSIDIARIES
EXHIBIT 23
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the incorporation by
reference of our report dated February 8, 1995, included in this Form 10-K,
into C. R. Bard, Inc.'s previously filed Registration Statements of Form S-8
for its Employees' Retirement Savings Plan of C. R. Bard, Inc.,
Registration No. 2-86291, the 1990 Employee Stock Option Plan, as amended,
Registration No. 33-35544 and the C. R. Bard, Inc. 1988 Directors Stock
Award Plan, as amended, and the 1993 Long Term Incentive Plan of C.R. Bard,
Inc., Registration No. 33-64874.
Arthur Andersen LLP /s/
Arthur Andersen LLP
Roseland, New Jersey
March 17, 1995
IV - 70
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-31-1994
<PERIOD-END> DEC-31-1994
<CASH> 34,200
<SECURITIES> 0
<RECEIVABLES> 187,300
<ALLOWANCES> 7900
<INVENTORY> 199,200
<CURRENT-ASSETS> 428,000
<PP&E> 199,900
<DEPRECIATION> 112,400
<TOTAL-ASSETS> 958,400
<CURRENT-LIABILITIES> 364,600
<BONDS> 78,300
<COMMON> 13,000
0
0
<OTHER-SE> 426,800
<TOTAL-LIABILITY-AND-EQUITY> 958,400
<SALES> 1,018,200
<TOTAL-REVENUES> 1,018,200
<CGS> 497,300
<TOTAL-COSTS> 370,200
<OTHER-EXPENSES> 32,600
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 15,100
<INCOME-PRETAX> 103,000
<INCOME-TAX> 28,100
<INCOME-CONTINUING> 74,900
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 74,900
<EPS-PRIMARY> 1.44
<EPS-DILUTED> 1.44
</TABLE>
